ArticleStatistics in medicine2026
A Bayesian Prevalence-Incidence Mixture Model for Screening Outcomes With Misclassification.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Screening and surveillance programs for cancer, such as colorectal cancer (CRC), often yield electronic health records (EHR) of screening time, test results, and covariates. We consider EHR from CRC surveillance of individuals who have a high cancer risk due to their family history. These individuals, therefore, receive regular colonoscopies with the goal of finding and removing adenomas, precursor lesions to CRC. Our objective is to estimate time to adenoma incidence and explore associations with covariates. However, in doing so, several challenges of the CRC surveillance EHR have to be addressed. Importantly, the adenoma events are interval-censored, meaning the exact event times are unknown and only fall within intervals defined by colonoscopy visits. Furthermore, colonoscopies can miss adenomas due to human or technical error, leading to misclassification of individuals with adenomas as adenoma-free. Finally, the EHR data include individuals with adenomas at baseline, termed prevalent cases. This prevalence status may be unobserved if the baseline colonoscopy is missing or fails to detect existing adenomas. To address these challenges in the CRC EHR, and screening data in general, we develop a new prevalence-incidence mixture model (PIM) with a Bayesian estimation back-end through data augmentation and regularization priors. We show how to fit the model, estimate cumulative incidence functions, and evaluate model fit using information criteria as well as a non-parametric estimator. In extensive simulations, we show good performance of the model when informative priors on the test sensitivity are provided, which is usually possible. An implementation in the R package BayesPIM is provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.